Cardiovascular Disease Prevention in Europe and Sub-Saharan Africa

NACompletedINTERVENTIONAL
Enrollment

583

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

January 5, 2022

Study Completion Date

January 5, 2022

Conditions
Cardiovascular Risk Factors
Interventions
OTHER

Multi-behavioral intervention

The interventional group will then meet regularly under the aegis of the trainer to work on modifying each person's risk factors. The one-hour sessions will be scheduled every two weeks for two months and then every month for two months and then every three months until the end of the study (13 sessions). These sessions will be behavior change sessions, focused on goal setting, action planning, and problem solving. Trainers will facilitate these sessions and use motivational interviewing techniques

Trial Locations (2)

29260

LE RESTE, Lanmeur

Unknown

LE GOFF, La Forest-Landerneau

All Listed Sponsors
collaborator

ERCR SPURBO

OTHER

lead

University Hospital, Brest

OTHER

NCT03886064 - Cardiovascular Disease Prevention in Europe and Sub-Saharan Africa | Biotech Hunter | Biotech Hunter